Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Labianca

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Drugs|April 1, 1997
Treatment of colorectal cancer. Current guidelines and future prospects for drug therapyR Labianca, M A Pessi, G Zamparelli
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
New strategies in colon cancer adjuvant therapyR Labianca, S Mosconi, M C Garassino
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Should patients with advanced colorectal cancer be treated with chemotherapy?G H Blijham, R Labianca, H Bleiberg
Journal of Cancer Research and Clinical Oncology|January 1, 1982
Antitumor chemotherapy after fluorouracil anginaG Beretta, R Labianca, F Montinari, et al.
La Radiologia Medica|April 1, 1981
[Medical treatment of bone metastases]G Beretta, R Labianca, P Fraschini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapyC Moro, R Taino, M Mandalà, et al.
The International Journal of Biological Markers|February 17, 2017
Development and clinical indications of cetuximabR Labianca, N La Verde, M C Garassino
Minerva Medica|March 17, 1980
[Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine]G Luporini, R Labianca, P Fraschini, et al.
The International Journal of Biological Markers|May 24, 2007
Development and clinical indications of cetuximabR Labianca, N La Verde, M C Garassino
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter studyV Heinemann, R Labianca, A Hinke, et al.
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Drugs|April 1, 1997
Treatment of colorectal cancer. Current guidelines and future prospects for drug therapyR Labianca, M A Pessi, G Zamparelli
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
New strategies in colon cancer adjuvant therapyR Labianca, S Mosconi, M C Garassino
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Should patients with advanced colorectal cancer be treated with chemotherapy?G H Blijham, R Labianca, H Bleiberg
Journal of Cancer Research and Clinical Oncology|January 1, 1982
Antitumor chemotherapy after fluorouracil anginaG Beretta, R Labianca, F Montinari, et al.
La Radiologia Medica|April 1, 1981
[Medical treatment of bone metastases]G Beretta, R Labianca, P Fraschini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapyC Moro, R Taino, M Mandalà, et al.
The International Journal of Biological Markers|February 17, 2017
Development and clinical indications of cetuximabR Labianca, N La Verde, M C Garassino
Minerva Medica|March 17, 1980
[Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine]G Luporini, R Labianca, P Fraschini, et al.
The International Journal of Biological Markers|May 24, 2007
Development and clinical indications of cetuximabR Labianca, N La Verde, M C Garassino
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter studyV Heinemann, R Labianca, A Hinke, et al.
Pageof 17